Molecular therapy for Myocardial ischemia: C/EBPβ inhibits cardiac ischemia via up regulation of Aldehyde dehydrogenase 2 (ALDH2), 28/March/2015, 23.03

Regenerative therapy for DM: RREB (Ras-responsive element-binding protein 1) promotes an insulin sensitized state via up regulation of reprogramming protein Lin28, 29/March/2015, 23.00
March 29, 2015
Natural product-based therapy for metastatic tumors: American ginseng inhibits epithelial-mesenchymal transition and cancer cell proliferation via down regulation of GLUT3, 29/March/2015, 23.08
March 29, 2015
Show all

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

CitationBoominathan, L., Molecular therapy for Myocardial ischemia: C/EBPβ inhibits cardiac ischemia via up regulation of Aldehyde dehydrogenase 2 (ALDH2), 28/March/2015, 23.03, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Significance: The study presented here suggests that C/EBPβ, by decreasing the expression of its target genes, it may increase the expression of Aldehyde dehydrogenase 2 (ALDH2). Thereby, it may inhibit Myocardial ischemia. Thus, pharmacological formulations encompassing “C/EBPβ activators” may be used to inhibit myocardial ischemia following myocardial infarction.

Undisclosed information: How  C/EBPβ increases the expression of Aldehyde dehydrogenase 2 (ALDH2)

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

Comments are closed.